Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18024860

Bevacizumab for the treatment of epithelial ovarian cancer: will this be its finest hour?

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 Nov 20
First author
Kaye SB

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Nov 20;25(33):5165-71. doi: 10.1200/JCO.2007.11.5345.
    note
    Source null
    related pmid
    18024863
    relationship
    Comment on
  2. citation
    J Clin Oncol. 2007 Nov 20;25(33):5180-6. doi: 10.1200/JCO.2007.12.0782.
    note
    Source null
    related pmid
    18024865
    relationship
    Comment on
  3. citation
    J Clin Oncol. 2008 Mar 20;26(9):1565-6. doi: 10.1200/JCO.2007.15.6448.
    note
    Source null
    related pmid
    18349413
    relationship
    Comment in

Authors and identifiers

  1. name
    Kaye SB
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kaye SB
    type
    Author
bibliography ids
  1. nci-bib-6e05c68cb9f17ec1c51a769d
book metadata
content sha256
357b2cb10f9510fa79e69c99a541311a71587ed46f90b54c94ac68d98a4d79f0
document type
citation
dois
  1. 10.1200/JCO.2007.13.6150
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:18024860
immutable id
pubmed:18024860@357b2cb10f9510fa79e69c99a541311a71587ed46f90b54c94ac68d98a4d79f0
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
33
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
5150-2
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Nov 20;25(33):5165-71. doi: 10.1200/JCO.2007.11.5345.
    note
    Source null
    related pmid
    18024863
    relationship
    Comment on
  2. citation
    J Clin Oncol. 2007 Nov 20;25(33):5180-6. doi: 10.1200/JCO.2007.12.0782.
    note
    Source null
    related pmid
    18024865
    relationship
    Comment on
  3. citation
    J Clin Oncol. 2008 Mar 20;26(9):1565-6. doi: 10.1200/JCO.2007.15.6448.
    note
    Source null
    related pmid
    18349413
    relationship
    Comment in
outcomes validated
false
pmid
18024860
provenance
batch id
89a0f2206e11ca092d02
provider
NCBI PubMed ESummary
record sha256
e41b36d1776aa0b084236dd88875c8a4407eb85503eb7020ad0a2f4a080db4e3
response sha256
7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
retrieved at
2026-09-09T23:46:16.784581+00:00
publication date
display
2007 Nov 20
precision
day
year
2007
publication types
  1. Comment
  2. Editorial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/18024860/
title
Bevacizumab for the treatment of epithelial ovarian cancer: will this be its finest hour?

Preserved source evidence · Not medical advice